These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 354301)

  • 1. Factors affecting the beta-cell sensitivity to alloxan in vivo. Influence of pre- and post-treatment with protective substances.
    Boquist L
    Acta Endocrinol (Copenh); 1978 Jul; 88(3):556-61. PubMed ID: 354301
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pancreatic B-cell sensitivity to alloxan in vivo. A study of antagonizing compounds, serum inorganic phosphate and acid-base balance.
    Boquist L
    Acta Pathol Microbiol Scand A; 1978 Jul; 86(4):313-8. PubMed ID: 362804
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of metabolic alkalosis on the B-cell sensitivity to alloxan in vivo.
    Boquist L
    Horm Metab Res; 1978 Nov; 10(6):477-81. PubMed ID: 33888
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential target molecules for toxicity induced by streptozotocin and alloxan in pancreatic islets of mice in vitro.
    Gai W; Schott-Ohly P; Schulte im Walde S; Gleichmann H
    Exp Clin Endocrinol Diabetes; 2004 Jan; 112(1):29-37. PubMed ID: 14758569
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alloxan diabetogenicity: determinants of potentiation, protection and B-cell selectivity.
    Boquist L
    Diabete Metab; 1989; 15(1):23-9. PubMed ID: 2542107
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of alloxan on the islets of Langerhans. Possible mechanisms of diabetogenic action.
    Borg LA
    Acta Biol Med Ger; 1981; 40(1):71-6. PubMed ID: 7020307
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reduction in the diabetogenic effect of alloxan in mice by treatment with the antineoplastic agent ICRF-187.
    El-Hage AN; Herman EH; Ferrans VJ
    Res Commun Chem Pathol Pharmacol; 1981 Sep; 33(3):509-23. PubMed ID: 7036302
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Studies on streptozotocin diabetes.
    Ganda OP; Rossini AA; Like AA
    Diabetes; 1976 Jul; 25(7):595-603. PubMed ID: 132382
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tilapia islet grafts are highly alloxan-resistant.
    Xu BY; Morrison CM; Yang H; Wright JR
    Gen Comp Endocrinol; 2004 Jun; 137(2):132-40. PubMed ID: 15158125
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alloxan-glucose interaction: effect on incorporation of 14C-leucine into pancreatic islets of rat.
    Bansal R; Ahmad N; Kidwai JR
    Acta Diabetol Lat; 1980; 17(2):135-43. PubMed ID: 7004041
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differences in the blood glucose response of mice to alloxan and alloxan-inhibiting compounds.
    Boquist L
    Acta Endocrinol (Copenh); 1979 Dec; 92(4):687-93. PubMed ID: 532524
    [No Abstract]   [Full Text] [Related]  

  • 12. The endocrine pancreas in early alloxan diabetes. Including study of the alloxan inhibitory effect of feeding and some hexoses.
    Boquist L
    Acta Pathol Microbiol Scand A; 1977 Mar; 85A(2):219-29. PubMed ID: 322443
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Protective effect of verapamil against alloxan-induced damage on pancreatic islet beta-cells in rats].
    Wei YJ; Yu GZ; Zhang GF; Yu JR
    Sheng Li Xue Bao; 1992 Apr; 44(2):209-14. PubMed ID: 1621112
    [TBL] [Abstract][Full Text] [Related]  

  • 14. p-Hydroxymercuribenzoate-induced hyperglycemia: influence of pre- and post-treatment with L-leucine, tolbutamide, D-mannoheptulose, insulin and alloxan.
    Boquist L
    J Endocrinol Invest; 1979; 2(4):413-7. PubMed ID: 395187
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of alloxan on insulin secretion in isolated rat islets perifused in vitro.
    Tomita T; Lacy PE; Natschinsky FM; McDaniel ML
    Diabetes; 1974 Jun; 23(6):517-24. PubMed ID: 4600579
    [No Abstract]   [Full Text] [Related]  

  • 16. Influence of alloxan administration on the blood glucose, islets of langerhans and some other tissues of the frog, Rana tigrina.
    Kumar S; Khanna SS
    Anat Anz; 1978; 143(3):242-9. PubMed ID: 356673
    [TBL] [Abstract][Full Text] [Related]  

  • 17. On the mechanism of glucose protection against alloxan toxicity.
    Scheynius A; Täljedal IB
    Diabetologia; 1971 Aug; 7(4):252-5. PubMed ID: 4937446
    [No Abstract]   [Full Text] [Related]  

  • 18. Effects of alloxan on electric activity of mouse pancreatic B cells in vitro.
    Shen XM; Su QF; Qian ZW; Zhang JR
    Zhongguo Yao Li Xue Bao; 1994 Sep; 15(5):439-42. PubMed ID: 7717071
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The protective effect of glucose, but not 3-O-methyl glucose, against alloxan-induced diabetes depends upon the route of hexose administration.
    Jansson L; Sandler S
    Arch Int Pharmacodyn Ther; 1988; 293():257-64. PubMed ID: 3048222
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Physiological and morphological changes in islet B cells following treatment of the guinea pig with alloxan.
    Gorray KC; Baskin DG; Fujimoto WY
    Diabetes Res; 1986 May; 3(4):187-91. PubMed ID: 3527515
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.